Unknown

Dataset Information

0

Computer-aided engineering of staphylokinase toward enhanced affinity and selectivity for plasmin.


ABSTRACT: Cardio- and cerebrovascular diseases are leading causes of death and disability, resulting in one of the highest socio-economic burdens of any disease type. The discovery of bacterial and human plasminogen activators and their use as thrombolytic drugs have revolutionized treatment of these pathologies. Fibrin-specific agents have an advantage over non-specific factors because of lower rates of deleterious side effects. Specifically, staphylokinase (SAK) is a pharmacologically attractive indirect plasminogen activator protein of bacterial origin that forms stoichiometric noncovalent complexes with plasmin, promoting the conversion of plasminogen into plasmin. Here we report a computer-assisted re-design of the molecular surface of SAK to increase its affinity for plasmin. A set of computationally designed SAK mutants was produced recombinantly and biochemically characterized. Screening revealed a pharmacologically interesting SAK mutant with ∼7-fold enhanced affinity toward plasmin, ∼10-fold improved plasmin selectivity and moderately higher plasmin-generating efficiency in vitro. Collectively, the results obtained provide a framework for SAK engineering using computational affinity-design that could pave the way to next-generation of effective, highly selective, and less toxic thrombolytics.

SUBMITTER: Nikitin D 

PROVIDER: S-EPMC8941168 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

altmetric image

Publications

Computer-aided engineering of staphylokinase toward enhanced affinity and selectivity for plasmin.

Nikitin Dmitri D   Mican Jan J   Toul Martin M   Bednar David D   Peskova Michaela M   Kittova Patricia P   Thalerova Sandra S   Vitecek Jan J   Damborsky Jiri J   Mikulik Robert R   Fleishman Sarel J SJ   Prokop Zbynek Z   Marek Martin M  

Computational and structural biotechnology journal 20220312


Cardio- and cerebrovascular diseases are leading causes of death and disability, resulting in one of the highest socio-economic burdens of any disease type. The discovery of bacterial and human plasminogen activators and their use as thrombolytic drugs have revolutionized treatment of these pathologies. Fibrin-specific agents have an advantage over non-specific factors because of lower rates of deleterious side effects. Specifically, staphylokinase (SAK) is a pharmacologically attractive indirec  ...[more]

Similar Datasets

| S-EPMC7869511 | biostudies-literature
| S-EPMC2832760 | biostudies-literature
| S-EPMC10877085 | biostudies-literature
| S-EPMC8761739 | biostudies-literature
| S-EPMC5855647 | biostudies-literature
| S-EPMC7294690 | biostudies-literature
| S-EPMC9768365 | biostudies-literature
| S-EPMC3807708 | biostudies-literature
| S-EPMC6441008 | biostudies-literature
| S-EPMC5831265 | biostudies-literature